rs11771429 - PAXBP1P1 - DPP6
Magnitude 2.2 · 1 study on file
Reported associations
-
A Genome-Wide Association Study Identifies New Susceptibility Loci for Esophageal Adenocarcinoma and Barrett's Esophagus - Unknown journal (n.d.) · Unknown authors · PubMed 24121790
[INTRO] Esophageal adenocarcinoma is a cancer with rising incidence and poor survival. Most such cancers arise in a specialized intestinal metaplastic epithelium, which is diagnostic of Barrett's esophagus. In a genome-wide association study, we compared esophageal adenocarcinoma cases (n=2,390) and patients with precancerous Barrett's esophagus (n=3,175) with 10,120 controls in two phases. For the combined case group we identified three new associations. The first is on 19p13 (rs10419226, P=3.6×10−10) in CRTC1 (CREB-regulated transcription co-activator), whose aberrant activation has been associated with oncogenic activity. A second is on 9q22 (rs11789015, P=1.0×10−9) in BARX1, which encodes a transcription factor important in esophageal specification. A third is on 3p14 (rs2687
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Screening
-
Barrett's esophagus screening Moderate
Genetic variant associated with 1.22-fold increased risk of Barrett's esophagus, a precancerous esophageal condition.
Discuss with gastroenterologist whether screening or surveillance is appropriate given this genetic risk factor.